(Q44199471)

30 November 2017

title

AL amyloidosis treated with induction chemotherapy with VAD followed by high dose melphalan and autologous stem cell transplantation (English)

1 reference

30 November 2017

1 reference

1 reference

Ingrid I van Gameren

1

1 reference

30 November 2017

Bouke P C Hazenberg

2

1 reference

30 November 2017

Piet L Jager

3

1 reference

30 November 2017

Jan W Smit

4

1 reference

30 November 2017

Edo Vellenga

5

1 reference

30 November 2017

publication date

1 September 2002

1 reference

30 November 2017

1 reference

30 November 2017

volume

9

1 reference

30 November 2017

issue

3

1 reference

30 November 2017

page(s)

165-174

1 reference

Treatment of 100 patients with primary amyloidosis: a randomized trial of melphalan, prednisone, and colchicine versus colchicine only.

30 November 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F13506120209114818

The treatment of multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506120209114818

Prognostic factors for survival and response after high-dose therapy and autologous stem cell transplantation in systemic AL amyloidosis: a report on 21 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506120209114818

Vincristine, doxorubicin and dexamethasone (VAD) administered as rapid intravenous infusion for first-line treatment in untreated multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506120209114818

Effective treatment of advanced multiple myeloma refractory to alkylating agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506120209114818

A quantitative method for detecting deposits of amyloid A protein in aspirated fat tissue of patients with arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506120209114818

Evaluation of systemic amyloidosis by scintigraphy with 123I-labeled serum amyloid P component

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506120209114818

Amyloid load and clinical outcome in AA amyloidosis in relation to circulating concentration of serum amyloid A protein

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506120209114818

Symptomatic ischemic heart disease resulting from obstructive intramural coronary amyloidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506120209114818

Eligibility for hematopoietic stem-cell transplantation for primary systemic amyloidosis is a favorable prognostic factor for survival

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506120209114818

10.3109/13506120209114818

21 January 2018

Identifiers

DOI

1 reference

30 November 2017

1 reference